We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

374 hedge funds and large institutions have $16.5B invested in Alnylam Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 137 increasing their positions, 109 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more first-time investments, than exits

New positions opened: 74 | Existing positions closed: 28

40% more capital invested

Capital invested by funds: $11.8B → $16.5B (+$4.72B)

38% more call options, than puts

Call options by funds: $154M | Put options by funds: $111M

26% more repeat investments, than reductions

Existing positions increased: 137 | Existing positions reduced: 109

13% more funds holding

Funds holding: 330 → 374 (+44)

1.28% more ownership

Funds ownership: 95.96% → 97.24% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

Holders
374
Holders Change
+44
Holders Change %
+13.33%
% of All Funds
7.67%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
74
Increased
137
Reduced
109
Closed
28
Calls
$154M
Puts
$111M
Net Calls
+$42.4M
Net Calls Change
+$22.3M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$186M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$143M
3
Blackstone Inc
Blackstone Inc
New York
+$125M
4
American Century Companies
American Century Companies
Missouri
+$79.6M
5
BlackRock
BlackRock
New York
+$74.2M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$245M
2
FCM
Farallon Capital Management
California
-$60.7M
3
Dodge & Cox
Dodge & Cox
California
-$52.5M
4
MC
Maverick Capital
Texas
-$30.5M
5
AG
Artal Group
Luxembourg
-$27M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
226
Frontier Capital Management
Massachusetts
$718K -$4.61M -34,187 -88%
OPPTF
227
OPSEU Pension Plan Trust Fund
Ontario, Canada
$715K +$652K +4,833 New
LSA
228
L & S Advisors
California
$704K +$325K +2,409 +103%
AAM
229
Advisors Asset Management
Colorado
$655K -$92.9K -689 -13%
Millennium Management
230
Millennium Management
New York
$646K -$13M -96,410 -96%
VEA
231
Virtus ETF Advisers
New York
$632K -$98.8K -733 -15%
M&T Bank
232
M&T Bank
New York
$626K +$72.3K +536 +15%
GIA
233
Gateway Investment Advisers
Ohio
$625K – – –
Commonwealth Equity Services
234
Commonwealth Equity Services
Massachusetts
$624K +$11.3K +84 +2%
NERM
235
New England Research & Management
Illinois
$607K +$553K +4,100 New
CIBC Asset Management
236
CIBC Asset Management
Ontario, Canada
$604K – – –
Daiwa Securities Group
237
Daiwa Securities Group
Japan
$585K – – –
Bank of Nova Scotia
238
Bank of Nova Scotia
Ontario, Canada
$554K +$504K +3,740 New
Parallax Volatility Advisers
239
Parallax Volatility Advisers
California
$550K +$305K +2,260 +155%
PAM
240
Panagora Asset Management
Massachusetts
$541K +$19.4K +144 +4%
APA
241
American Portfolios Advisors
New York
$531K +$483K +3,586 New
Schroder Investment Management Group
242
Schroder Investment Management Group
United Kingdom
$524K +$207K +1,534 +77%
B
243
Bailard
California
$518K – – –
CBB
244
Citizens Business Bank
California
$518K – – –
EGM
245
Engineers Gate Manager
New York
$518K +$472K +3,500 New
BS
246
Banco Santander
Spain
$508K +$462K +3,429 New
CANY
247
Caxton Associates (New York)
New York
$508K +$463K +3,431 New
IRF
248
IBM Retirement Fund
New York
$493K +$19K +141 +4%
TC
249
Telemus Capital
Michigan
$487K – – –
Lazard Asset Management
250
Lazard Asset Management
New York
$481K +$278K +2,065 +174%
8 9
10
11 12

ALNY Hedge Fund Activity: Q2 2020 in Review

374 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q2 2020, worth a combined $16.5B — up 40% from $11.8B a quarter earlier.

Buyers outnumbered sellers: 74 funds opened new ALNY positions and 28 closed out — a net gain of 46 holders — while 137 added to existing stakes and 109 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $186M. The largest seller was Wellington Management Group, cutting an estimated $245M.

  • 374 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q2 2020, up from 330 in Q1 2020.
  • Funds reported $16.5B of Alnylam Pharmaceuticals stock for Q2 2020, up 40% quarter-over-quarter.
  • 74 funds opened new Alnylam Pharmaceuticals positions in Q2 2020 and 28 closed out, a net change of +46 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q2 2020 was JP Morgan Chase, an estimated $186M added.
  • The largest Alnylam Pharmaceuticals seller in Q2 2020 was Wellington Management Group, an estimated $245M sold.

Based on aggregated 13F filings for Q2 2020.